Severe congenital neutropenia (SCN), also often known as Kostmann syndrome or disease, is a group of rare disorders that affect myelopoiesis, causing a congenital form of neutropenia, usually without other physical malformations. SCN manifests in infancy with life-threatening bacterial infections.[2]
Most cases of SCN respond to treatment with granulocyte colony-stimulating factor(filgrastim), which increases the neutrophil count and decreases the severity and frequency of infections.[2] Although this treatment has significantly improved survival, people with SCN are at risk of long-term complications such as hematopoietic clonal disorders (myelodysplastic syndrome, acute myeloid leukemia).
Kostmann disease (SCN3), the initial subtype recognized, was clinically described in 1956. This type has an autosomal recessive inheritance pattern, whereas the most common subtype, SCN1, shows autosomal dominant inheritance.
Severe congenital neutropenia
Other names Kostmann disease, Kostmann's agranulocytosis, Kostmann's syndrome, congenital agranulocytosis, congenital neutropenia, permanent neutropenia, infantile genetic agranulocytosis, severe infantile genetic neutropenia
Specialty Hematology
Usual onset Infancy[1]
Types SCN1-SCN5, SCNX
Causes Mutation in genes, depending on type[1]
Diagnostic method Blood test, genetic testing[1]
Treatment G-CSF, HSCT[1]
Medication Filgrastim[1]
Frequency 2-3 in million (2018)[1]
- Syndromes affecting blood
- Congenital defects of phagocyte number, function, or both
- Autosomal recessive disorders
- Autosomal dominant disorders
- Enzyme defects
- Rare diseases
https://en.wikipedia.org/wiki/Severe_congenital_neutropenia
No comments:
Post a Comment